Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors
JAMA Network Open · 31.05.2023 · 6 (5) · e2316077
DOI: 10.1001/jamanetworkopen.2023.16077 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 31.05.2023. Verfasst von Nicholas S Phillips und 14 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Cancer Control Department, St Jude Children's Research Hospital, Memphis, Tennessee. Hauptthemen laut MEDLINE: Cancer Survivors, Cognitive Dysfunction, Central Nervous System Neoplasms. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance Long-term survivors of childhood cancer may be at elevated risk for new neurocognitive impairment and decline as they age into adulthood.
Objective
To determine whether aging adult childhood cancer survivors report more new-onset neurocognitive impairments compared with their siblings and to identify risk factors associated with such impairments. Design, Setting, and Participants Participants of this cohort study included adult survivors of childhood cancer from the Childhood Cancer Survivor Study and their siblings as a control group. The original cohort included survivors who received a diagnosis between January 1, 1970, and December 31, 1986, for whom longitudinal neurocognitive assessment was available. This study examined the prevalence of new-onset neurocognitive impairment between baseline (23.4 years after diagnosis) and follow-up (35.0 years after diagnosis). The analysis was performed from January 2021 to May 2022. Exposures Cancer treatment exposures were abstracted from medical records. Chronic health conditions were graded using Common Terminology Criteria for Adverse Events version 4.03. Main Outcomes and Measures The primary outcome was new-onset (present at follow-up, but not present at baseline) neurocognitive impairment (defined as a score in the worst 10% of the sibling cohort). Impairment was assessed using the Childhood Cancer Survivor Study Neurocognitive questionnaire. Relative risks (RRs) and 95% CIs were used to estimate associations of neurocognitive impairment with treatment and health behaviors and conditions using generalized linear models.
Results
The cohort comprised 2375 survivors (mean [SD] age at evaluation, 31.8 [7.5] years; 1298 women [54.6%]) of childhood cancer, including acute lymphoblastic leukemia (ALL; 1316 participants), central nervous system (CNS) tumors (488 participants), and Hodgkin lymphoma (HL; 571 participants). A total of 232 siblings (mean [SD] age at evaluation, 34.2 [8.4] years; 134 women [57.8%]) were included. Compared with siblings, a higher proportion of survivors with no impairment in memory at baseline had new-onset memory impairment at follow-up: siblings proportion, 7.8% (95% CI, 4.3%-11.4%); ALL survivors treated with chemotherapy only, 14.0% (95% CI, 10.7%-17.4%); ALL survivors treated with cranial radiation (CRT), 25.8% (95% CI, 22.6%-29.0%); CNS tumor survivors, 34.7% (95% CI, 30.0%-39.5%); and HL survivors, 16.6% (95% CI, 13.4%-19.8%). New-onset memory impairment was associated with CRT in CNS tumor survivors (RR, 1.97; 95% CI, 1.33-2.90) and alkylator chemotherapy greater than or equal to 8000 mg/m 2 in ALL survivors treated without CRT (RR, 2.80; 95% CI, 1.28-6.12). Neurologic conditions mediated the impact of CRT on new-onset memory impairment in CNS survivors. Smoking, low educational attainment, and low physical activity were associated with elevated risk for new-onset memory impairment. Conclusions and Relevance These findings suggest that adult survivors of childhood cancer are at elevated risk for late-onset memory impairment related to modifiable risk factors identified early in survivorship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Epidemiology and Cancer Control Department, St Jude Children's Research Hospital, Memphis, Tennessee.
- Department of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
- Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York City, New York.
- Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
- Department of Psychology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
- Department of Radiation Physics, MD Anderson Cancer Center, Houston, Texas.
Förderung
- NCI NIH HHS
Zitieren
APA
Phillips, N. S., Stratton, K. L., Williams, A. M., Ahles, T., Ness, K. K., Cohen, H. J., Edelstein, K., Yasui, Y., Oeffinger, K., Chow, E. J., Howell, R. M., Robison, L. L., Armstrong, G. T., Leisenring, W. M., & Krull, K. R. (2023). Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors. JAMA Network Open, 6(5), e2316077. https://doi.org/10.1001/jamanetworkopen.2023.16077
Vancouver
Phillips NS, Stratton KL, Williams AM, Ahles T, Ness KK, Cohen HJ, et al. Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors. JAMA Network Open. 2023;6(5):e2316077. doi:10.1001/jamanetworkopen.2023.16077
BibTeX
@article{Phillips2023,
author = {Phillips, Nicholas S and Stratton, Kayla L and Williams, AnnaLynn M and Ahles, Tim and Ness, Kirsten K and Cohen, Harvey Jay and Edelstein, Kim and Yasui, Yutaka and Oeffinger, Kevin and Chow, Eric J and Howell, Rebecca M and Robison, Leslie L and Armstrong, Gregory T and Leisenring, Wendy M and Krull, Kevin R},
title = {Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {5},
pages = {e2316077},
doi = {10.1001/jamanetworkopen.2023.16077}
}
EUVIMED